Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.
about
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpressionCurrent and future pharmacological treatment strategies in X-linked adrenoleukodystrophyPotential Role of Epigenetic Mechanism in Manganese Induced NeurotoxicityThe Interaction between Obstructive Sleep Apnea and Parkinson's Disease: Possible Mechanisms and Implications for Cognitive FunctionMitochondrial biology and Parkinson's diseaseMetabolic syndrome: an important risk factor for Parkinson's diseaseOxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiaeTranslation initiator EIF4G1 mutations in familial Parkinson diseaseParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisPolychlorinated biphenyls in prospectively collected serum and Parkinson's disease riskGenetic modification of the association of paraquat and Parkinson's diseaseBeneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in ratsα-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activityEquol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In VitroParkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundanceMitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewalAssociation of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomicsMemory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's diseaseOxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood.Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.Effects of acute dieldrin exposure on neurotransmitters and global gene transcription in largemouth bass (Micropterus salmoides) hypothalamusPersistent changes in neuronal structure and synaptic plasticity caused by proton irradiation.SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's diseaseCART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria.An association study between Heme oxygenase-1 genetic variants and Parkinson's disease.Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.The regulation of catalase activity by PPAR γ is affected by α-synuclein.Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseHMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.Drosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO.Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neuronsMutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationSynergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated NeurodegenerationSumoylation inhibits alpha-synuclein aggregation and toxicity.Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.
P2860
Q22001521-4404753C-AC93-4E23-BD70-BEB806B09CCFQ24618949-C7F6A9C2-7D32-4965-9095-39866AC5CD5FQ26744563-12B0AC3A-B9EA-4F0D-A0B6-6993CD3F4D45Q26778246-055CE2B1-C5D8-4202-A0B6-F12460CA5905Q26824090-F662934C-C183-490D-AD32-7CD9C9F829CEQ27023711-4938F4B4-3080-475F-A802-9AC5C3D9AE1CQ27692067-02BAAC02-4ACA-48BB-843B-07D52F61A122Q28247679-50606E2D-6891-47A2-A967-141A4B31204BQ28384572-C4B8FACB-97A2-4B55-B99F-D1CBEE94108CQ28391573-CB8E88B9-F784-4E19-8E16-B6241D914DCCQ28394396-F91A7D7F-F921-4B13-952D-7B836016AC0BQ28473890-37F90990-07D1-4FE0-AC22-E5A34CA39D9AQ28572683-14F490CB-7B01-48F0-A8F9-31830952BFD3Q29248888-BCCAAA10-B248-4E2F-B08B-3C02711206ACQ30438194-6EFAF81E-C4BE-4A69-8B98-4609A1F5824BQ30501000-BA591739-F3BF-44BC-BE6E-07A0C703DC93Q33536124-CE853F9B-4187-46AC-B0FD-2D84F5060B55Q33605431-4EBCC7E3-081A-469B-9F51-06B10CC1DDDEQ33606408-EA2A7D8A-4FB9-4093-A7E6-1486F9ABEFD8Q33645487-0F28BB98-1F31-45C8-A104-B0C9FF146FF6Q33654222-1DF8EA3E-28CB-47BE-8ED3-ACA95B5577CFQ33901028-F290A561-FC67-4344-A605-B79F34AC6FFEQ33927447-46DB9574-2A66-4E47-8603-B0456A080D95Q33944220-00D74F9C-B578-4D28-8242-E71599D5DAF6Q34123653-47F99908-E483-4F63-B537-73C2B2FC2192Q34238382-69970CCE-4BDA-430A-866C-F16AF2192716Q34245004-D3DC293E-08D9-4802-B9EE-824C7F6FF8B8Q34286365-EBDB2F84-304B-4EE8-AE54-9BA9ACE6ED41Q34313803-AFAD370F-C49A-4D98-BB18-5D0E32D2EB3BQ34615988-1C3A2925-4F10-4B93-B8EC-CECB9C0F0AF8Q34631169-38A8263D-BE76-448D-97C4-44B11CBA0601Q34671965-D850A8D6-277E-400F-84A6-EAFCA3EE425BQ34770689-2335A094-144E-41B1-8DAB-BF1F93B30BCAQ34944325-1FA8B3FE-6D7D-4F0A-A0A9-20A88DF9AC9AQ34976266-A18FA212-3FB8-4709-8113-BDC4CDA92AF9Q35078638-AEC66904-1E5A-49A8-983C-A6D9CD8210F8Q35101698-DF4B56CE-D506-41F4-BD63-35224DE2A94FQ35102441-7EEF2B47-C0D9-48DB-86EF-041C6B2C6429Q35104608-6E900A23-0B7D-4913-B17C-0AAE9CB46CE1Q35147689-808F8818-A527-4C16-B710-4BD0D955B8EB
P2860
Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oxidative stress in Parkinson' ...... and therapeutic significance.
@en
Oxidative stress in Parkinson' ...... and therapeutic significance.
@nl
type
label
Oxidative stress in Parkinson' ...... and therapeutic significance.
@en
Oxidative stress in Parkinson' ...... and therapeutic significance.
@nl
altLabel
Oxidative Stress in Parkinson's Disease
@en
prefLabel
Oxidative stress in Parkinson' ...... and therapeutic significance.
@en
Oxidative stress in Parkinson' ...... and therapeutic significance.
@nl
P2860
P356
P1476
Oxidative stress in Parkinson' ...... and therapeutic significance.
@en
P2093
P2860
P304
P356
10.1196/ANNALS.1427.023
P407
P577
2008-12-01T00:00:00Z